News

Viewing Page 1 of 1 | Showing Results 1 - 6 of 6

In a rare procedure, a Providence patient gets a new jaw, complete with teeth, in one day

April 19, 2019

The complex procedure, known as a “Jaw in a Day,” has been performed in only a few highly specialized centers in the world. Smith’s procedure, performed in August at Providence St. Vincent Medical Center, was the first on the West Coast.

The cancer never took her heart and soul

July 19, 2018

In 2005, Becky Roth's dentist discovered a white spot on her tongue. It was benign, but five years later another spot led to the discovery of a tumor at the base of her tongue and jaw.

Cancer Survivor Inspires 'Creating Hope' Donors; Event Breaks Record to Support Providence Research and Treatment

June 11, 2018

In a powerful speech to a packed house, Becky Roth spoke emotionally about the cancer that changed, but didn’t claim, her life. And, despite losing two leg bones used for her jaw reconstruction – and against all odds – she will run in the 2018 Providence Hood to Coast relay race to raise money for cancer research at Providence.

Transoral robotic surgery yields benefits for Providence throat cancer patients

March 12, 2018

A recent assessment of the first 170 throat-cancer patients treated with transoral robotic surgery followed by risk-adapted adjuvant therapy at Providence Cancer Institute offers compelling evidence in favor of this new treatment approach.

Providence opens groundbreaking immunoradiotherapy clinical trial for patients with newly diagnosed head and neck cancer

March 08, 2018

Many clinical trials are open only to patients with metastatic disease. One of the translational research goals of the Providence Head and Neck Cancer Program is to bring immunotherapy into treatment earlier.

Adoptive T-cell transfer study opens for head and neck cancer patients

March 05, 2018

Adoptive T-cell transfer therapy is emerging as one of the most effective treatments to date for people with advanced melanoma. Now this treatment is available to patients with advanced or recurrent head and neck cancers through a clinical trial at Providence Cancer Institute.

Viewing Page 1 of 1 | Showing Results 1 - 6 of 6